|Slideshows|July 18, 2019

What's to come for AI

Author(s)Andrew J Schuman, MD

Dr. Andrew J. Schuman looks at the artificial intelligence (AI) programs that may be found in your practice sooner rather than later.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

A teenaged girl with flat-topped papules

A teenaged girl with flat-topped papules

ByZeena Mestari,Bernard A Cohen, MD

September 9th 2026

Vosoritide improves growth velocity in children with hypochondroplasia, phase 3 trial shows | Image Credit: © HockleyM2/peopleimages.com - stock.adobe.com.

Vosoritide improves growth velocity in children with hypochondroplasia, phase 3 trial shows

ByMorgan Ebert, Executive Editor

September 9th 2026

CDC-backed surveillance finds 4 in 5 child deaths preventable across 7 high-mortality countries | Image Credit: © JHVEPhoto - stock.adobe.com.

CDC-backed surveillance finds 4 in 5 child deaths preventable across 7 high-mortality countries

ByMorgan Ebert, Executive Editor

September 9th 2026

Semaglutide improves BMI category in children aged 6 to 11 years in phase 3 trial | Image Credit: © Peter Hansen - stock.adobe.com.

Semaglutide improves BMI category in children aged 6 to 11 years in phase 3 trial

ByMorgan Ebert, Executive Editor

September 8th 2026

ARTEMIS trial data show Bifidobacterium-HMO synbiotic is safe and colonizes the infant, toddler gut | Image Credit: © Emiliia - stock.adobe.com.

ARTEMIS trial data show Bifidobacterium-HMO synbiotic is safe and colonizes the infant, toddler gut

ByMorgan Ebert, Executive Editor

September 8th 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

CDC-backed surveillance finds 4 in 5 child deaths preventable across 7 high-mortality countries

Vosoritide improves growth velocity in children with hypochondroplasia, phase 3 trial shows

Semaglutide improves BMI category in children aged 6 to 11 years in phase 3 trial

Abbott launches first ready-to-feed whole milk infant formula in the U.S.

A teenaged girl with flat-topped papules